Biological, psychosocial, therapeutic and quality of life inequalities between HIV-positive men and women - A review from a gender perspective

AIDS Reviews

Volumn 12, Issue 2, 2010, Pages 113-120

  Del Castillo, Luis Sordo ^a,c   Ruiz Pérez, Isabel ^b,c   Olry De Labry Lima, Antonio ^b,c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Gender; HIV; Psychological factors; Quality of life; Therapeutics

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; EFAVIRENZ; NELFINAVIR; ORAL CONTRACEPTIVE AGENT; RITONAVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANATOMICAL VARIATION; CONDOM; DRUG INHIBITION; FEMALE GENITAL SYSTEM; GENDER VIOLENCE; HEALTH CARE COST; HEALTH CARE DISPARITY; HEALTH CARE UTILIZATION; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRATION; INFECTION RISK; INFECTION SENSITIVITY; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIMARY PREVENTION; PROSTITUTION; PUBLIC HEALTH SERVICE; QUALITY OF LIFE; REVIEW; SELF ESTEEM; SEX DIFFERENCE; SEXUAL ABUSE; SEXUAL EDUCATION; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; SOCIOECONOMICS; SURVIVAL; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CARCINOMA; VIOLENCE; VIRUS TRANSMISSION; DISEASE TRANSMISSION; FEMALE; GENDER IDENTITY; MALE; PATHOLOGY; PSYCHOLOGICAL ASPECT;

ANTI-HIV AGENTS; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; GENDER IDENTITY; HIV INFECTIONS; HUMANS; MALE; QUALITY OF LIFE; SEX FACTORS;

EID: 77956689529     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Joint United Nations Program on HIV/AIDS. AIDS epidemic update. Geneva: World Health Organization, November 2009.
2. Quinn T, Overbaugh J. HIV/AIDS in women: An expanding epidemic. Science. 2005;308:1582-3. (Pubitemid 40807496)
3. Centers for Disease Control and Prevention (CDC). Persons tested for HIV-United States, 2006 MMWR. 2008,57.845-9.
4. Ostermann J, Kumar V, Pence B, Whetten K Trends in HIV testing and differences between planned and actual testing in the United States, 2000-2005. Arch Intern Med. 2007,167:2128-35.
5. Shah R, Bradbeer C. Women and HIV revisited ten years. Int J STD AIDS. 2000,11.277-83.
6. Cederfjall C, Langius-Eklof A, Lidman K, Wredling R. Gender differences in perceived health- related quality of life among patients with HIV infection. AIDS Patient Care ST. 2001,15:31-9. (Pubitemid 32104584)
7. Palacio H, Shiboski C, Yelin E, Hessol N, Greenblatt R. Access to and utilization of primary care services among HIV-infected women. J Acquir Immune Defic Syndr. 1999;21:293-300. (Pubitemid 29357660)
8. Serovich J, Kimberly J, Mosack K, Lewis T. The role of family and friend social support in reducing emotional distress among HIV-positive women. AIDS Care. 2001:13.335-41.
9. Kenagy G. The risk less known female to male transgender person's vulnerability to HIV infection. AIDS Care. 2005:17.195-207.
10. Dworkin S Who is epidemiologically fathomable in the HIV/AIDS epidemic? Gender, sexuality, and intersectionality in public health Cult Health Sex 2005:7.615-23.
11. Krug E, Mercy J, Dahlberg L, Zwi A. The first World Report on violence and health. Lancet. 2002;360:1083-8.
12. Dunkle K, Jewkes R. Effective HIV prevention requires gender-transformative work with men. Sex Transm Infect. 2007,83.173-4
13. Cohen M, Deamant C, Barkan S, et al. Domestic violence and childhood sexual abuse in HIV-infected women and women at risk for HIV Am J Public Health. 2000:4-560-5.
14. García-Moreno C, Watts C. Violence against women: It's important for HIV/AIDS. AIDS 2000;14-253-65.
15. Culbertson F. Depression and gender. An international review. Am Psychol 1997;52:25-31. (Pubitemid 127458596)
16. Remien R, Exner T, Kertzner R, et al. Depressive Symptomatology among HIV-positive women in the era of HAART: A stress and coping model. Am J Community Psychol. 2006,38:275-85. (Pubitemid 44878178)
17. Cook J, Grey D, Burke J, et al. Depressive symptoms and AIDS-related mortality among a multiSite cohort of HIV-positive women. Am J Public Health. 2004,94-1133-40. (Pubitemid 38857313)
18. Cook J, Cohen M, Burke J, et al. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-serapositive women. J Acquir Immune Defic Syndr. 2002;30:401-9. (Pubitemid 34857314)
19. Tsao J, Dobalian A, Moreau C, Dobalian K. Stability of anxiety and depression in a national sample of adults with HIV J Nerv Ment Dis. 2004;192:111-18.
20. Turner B, Laine C, Cosier L, Hauck W Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med. 2003,18.248-57.
21. Gebo K, Fleishman J, Conviser R, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr. 2005;38:96-103.
22. Hough E, Magnan M, Templin T, Gadelrab H. Social network structure and social support in HIV-positive inner city mother. J Assoc Nurses AIDS Care. 2005,16.14-24.
23. Hera M, Ferreros I, Del Amo J, et al. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001. J Epidemiol Community Health. 2004;58 944-50.
24. Ruiz I, Aviñó M, Bonora V, et al. Morbilidad psíquica y nivelés de apoyo social en una cohorte de sujetos seropositives trente al VIH. Gac Sanit. 1999:13:9116.
25. McDowell T, Serovich J. The effect of perceived and actual social support on the mental health of HIV-positive persons. AIDS Care. 2007,19.1223-9.
26. Dezzutti C, Guenthner P, Cummins J, et al Cervical and prostate primary epithelial cells are not productively infected but sequester HIV type 1. J Infect Dis. 2001,183.1204-13
27. Cummins J, Dezzutti C. Sexual HIV-1 Transmission and mucosal defense mechanisms. AIDS Rev. 2000,2.144-54
28. Wiesenfeld H, Lowry D, Heine R, et al. Self-collection of vaginal swabs for the detection of chlamydia, gonorrhea, and trichomoniasis: Opportunity to encourage STD testing among adolescents. Sex Transm Dis. 2001,28.321-5.
29. Gandhi M, Bacchetti P, Miotti P, Quinn T, Veronese F, Greenblatt R. Does patient sex affect human immunodeficiency virus levels? Clin Infect Dis. 2002,35:313-22
30. Sun X, Kuhn L, Ellerbrock T, Chiasson A, Bush T, Wright T. Human papillomavirus infection in women infected with the HIV. N Engl J Med 1997,337.1343-9.
31. Ramjee G, Doncel G, Mehendale S, Tolley E, Dickson K Microbicides 2008 Conference: From Discovery to Advocacy. AIDS Res Ther. 2008;5:19.
32. Kigozi G, Gray R, Wawer M, et al. The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda. PLoS Med. 2008,5:911-19.
33. Buchbinder S. HIV testing and prevention strategies. Top HIV Med 2008:16-9-14.
34. Quinn T. Circumcision and HIV transmission. Curr Opin Infect Dis. 2007,20-33-8.
35. Hernando V, del Romero J, García S, Rodríguez C, del Arno J, Castilla J. Reducing sexual risk behavior among steady heterosexual serodiscordant couples in a testing and counseling program. Sex Transm Dis. 2009;36:621-8.
36. Castilla J, Del Romero J, Hernando V, Marincovich B, García S, Rodríguez C Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J AIDS. 2005;40:96-101. (Pubitemid 41233212)
37. Barreiro P, Castilla J, Labarga P, Soriano V Is natural conception a valid option for HIV-serodiscordant couples? Hum Reprod 2007:22.2353-8.
38. Barreiro P, Duerr A, Beckerman K, Soriano V. Reproductive options for HIV-serodiscordant couples. AIDS Rev 2006,8-158-70. (Pubitemid 44614033)
39. Gupta G. How men's power over women fuels the HIV epidemic. BMJ. 2002,321:183-4. (Pubitemid 34107078)
40. Shevitz A, Pagano M, Chiasson M, Mueller N, Thomas P. The association between youth, women, and acquired immunodeficiency syndrome. J Acquir Inmune Syndr Hum Retroviral. 1996;13:427-33. (Pubitemid 26425341)
41. Green E, Halperin D, Nantulya V, Hogle J. Uganda's HIV prevention success: the role of sexual behavior chance and the national response. AIDS Behav 2006;10:335-46. (Pubitemid 44174960)
42. Halperin D, Steiner M, Cassell M, et al. The time has come for common ground on preventing sexual transmission of HIV Lancet. 2004;364:1913-15. (Pubitemid 39574574)
43. Hunter M. Cultural politics and masculinities: multiple partners in historical perspective in KwaZulu-Natal. Cult Health Sex. 2005;7-389-403.
44. Hellinger F. The use of health services by women with HIV infection. Health Serv Res. 1993;28:543-61. (Pubitemid 24011916)
45. Smith S, Kirking D. Access and use of medications. Health Serv Res. 1999,34 123-44
46. Solomon L, Stein M, Flynn C, et al. Health services use by urban women with or at risk for HIV-1 infection. The HIV Epidemiology Research Study (HERS). J Acquir Immune Defic Syndr. 1998,17-253-61.
47. Gebo K, Diener-West M, Moore R. Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;27.143-52.
48. García de la Hera M, Ruiz Pérez I, Hernández-Aguado I, Aviñó M, Pérez-Hoyos S, González-Aracil J Gender differences in HIV risk behavior of intravenous drug users who are not prostitutes Woman Health. 2001:34 1-13.
49. Hader S, Smith D, Moore J, Holmberg S. HIV Infection in women in the United States: Status at the millennium. JAMA. 2001,285:1186-92. (Pubitemid 32198485)
50. Bertakis K, Azari R, Helms L, Callahan E, Robins J. Gender differences in the utilisation of health services. J Fam Pract. 2000,49.147-52.
51. Box T, Olsen M, Oddone E, Keitz S Healthcare access and utilization by patients infected with HIV: does gender matter? Woman Health. 2003;12:391-7.
52. Hall H, Li J, Campsmith M, Sweeny P, Lee L. Date of first positive HIV test, reliability of information collected for HIV/AIDS surveillance in the United States. Public Health Rep. 2005,120:89-95. (Pubitemid 40965709)
53. Fardet L, Mary-Krause M, Heard I, Partisani M, Costagliola D. Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response. HIV Med. 2006:7-520-9.
54. Mocroft A, Gill M, Davidson W, Phillips A. Are there gender differences in starting PI's, HAART, and disease progression despite equal access to care? J Acquir Immune Defic Syndr. 2000:24 475-82.
55. Centers for Disease Control and Prevention. Report of NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR. 1998:47.1-82.
56. Gandhi M, Bacchetti P, Miotti P, et al. Does patient sex affect HIV levels? Clin Infect Dis. 2002,35 313-22.
57. Nicastri E, Angeletti C, Palmisano L, et al. Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy AIDS. 2005,19 577-83
58. Sterling T, Vlahov D, Astemborski J, Hoover D, Margolick J, Quinn T. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med 2001,344:720-5. (Pubitemid 32204989)
59. Napravnik S, Poole C, Thomas J, Eron J Gender difference in HIV RNA levels: a meta analysis of published studies. J Acquir Immune Defic Syndr. 2002,31.11-19.
60. Pérez-Hoyos S, Ferreras I, del Arno J, et al. Survival and progression to AIDS in a seroconverter cohort in the post-highly active antiretroviral therapy era: effectiveness goes on. AIDS. 2006;20.289-91.
61. Hammer S, Eron J, Reiss P, et al. Antiretroviral treatment of adult infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008:300-555-70.
62. Johnston R, Mann T. Barriers to antiretroviral medication adherence in HIV-infected women. AIDS Care. 2000,12:377-86. (Pubitemid 30618182)
63. Mrus J, Williams P, Tsevat J, Cohn S, Wu A. Gender differences in health-related quality of life in patients with HIV/AIDS. Qual Life Res. 2005,14:479-91. (Pubitemid 40576398)
64. Plach S, Stevens P, Heidrich S Social roles and health in women living with HIV/AIDS: a pilot study. J Assoc Nurses AIDS Care. 2006,17:58-64. (Pubitemid 43562450)
65. Perez I, Olry de Labry Lima A, del Castillo L, Bano J, Ruz M, del Arco Jimenez A No differences in quality of life between men and women undergoing HIV antiretroviral treatment. Impact of demographic, clinical and psychosocial factors. AIDS Care. 2009;21:943-52.
66. Cowdery J, Pesa J. Assessing quality of life in women living with HIV infection. AIDS Care. 2002,14 235-45. (Pubitemid 34407283)
67. Holzemer W, Gygax J, Skodol H, Kemppainen J, Coleman C Validation of the quality of life scale: living with HIV. J Adv Nurs. 1998;28:622-30. (Pubitemid 128454025)
68. Wu A, Revicki D, Jacobson D, Malitz F. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res. 1997;6:481-93. (Pubitemid 27431704)
69. Berg K, Demas P, Howard A, Schoenbaum E, Gourevitch M, Arnsten J Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med. 2004,19.1111-17.